ZORYVE

ROFLUMILAST · Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ZORYVE, covering 2022-07-29 to 2025-10-04. Get the full timeline:

Most recent: FDA Approved: ZORYVE — Supplemental Application (Arcutis Biotherapeutics, Inc.)